Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Zota Health Care Q2 Review: Nirmal Bang Trims Target Price But Retains Rating; Details Inside

    1 day ago

    The brokerage expects revenues to clock a compound annual growth rate of 62% over FY26FY28E, driven by store additions, improved operations and continued network scale-up.
    Click here to Read More
    Previous Article
    Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
    Next Article
    Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment